DNA icon

Comprehensive Cataracts Panel

Summary and Pricing

Test Method

Exome Sequencing with CNV Detection
Test Code Test Copy Genes Gene CPT Codes Copy CPT Codes
ABCB6 81479,81479
ADAMTS10 81479,81479
AGK 81479,81479
AGPS 81479,81479
AKAP14 81479,81479
ALDH18A1 81479,81479
ALPL 81479,81479
B3GLCT 81479,81479
BCOR 81479,81479
BEST1 81406,81479
BFSP1 81479,81479
BFSP2 81479,81479
BMP4 81479,81479
BMP7 81479,81479
CAPN15 81479,81479
CCNP 81479,81479
CHMP4B 81479,81479
COL11A1 81479,81479
COL18A1 81479,81479
COL2A1 81479,81479
COL4A1 81408,81479
COL4A2 81479,81479
CRYAA 81479,81479
CRYAB 81479,81479
CRYBA1 81479,81479
CRYBA4 81479,81479
CRYBB1 81479,81479
CRYBB2 81479,81479
CRYBB3 81479,81479
CRYGB 81479,81479
CRYGC 81479,81479
CRYGD 81479,81479
CRYGS 81479,81479
CTDP1 81479,81479
CYP27A1 81479,81479
DHCR7 81405,81479
ELP4 81479,81479
EPG5 81479,81479
EPHA2 81479,81479
ERCC1 81479,81479
ERCC2 81479,81479
ERCC5 81479,81479
ERCC6 81479,81479
ERCC8 81479,81479
ESCO2 81479,81479
EVA1A 81479,81479
EYA1 81406,81405
FAM131A 81479,81479
FBN1 81408,81479
FOXC1 81479,81479
FOXE3 81479,81479
FTL 81479,81479
FYCO1 81479,81479
FZD4 81479,81479
GALK1 81479,81479
GCNT2 81479,81479
GJA1 81479,81479
GJA3 81479,81479
GJA8 81479,81479
GJC3 81479,81479
GLA 81405,81479
GNPAT 81479,81479
GPR160 81479,81479
GRWD1 81479,81479
HCCS 81479,81479
HMX1 81479,81479
HSF4 81479,81479
HYCC1 81479,81479
INPP5B 81479,81479
JAM3 81479,81479
KLHL21 81479,81479
LAMB1 81479,81479
LARGE1 81479,81479
LCT 81479,81479
LENG8 81479,81479
LIM2 81479,81479
LMX1B 81479,81479
LRP5 81406,81479
LTBP2 81479,81479
LTBP3 81479,81479
MAB21L1 81479,81479
MAF 81479,81479
MAN1C1 81479,81479
MAN2B1 81479,81479
MAP6D1 81479,81479
MECR 81479,81479
MEIS1 81479,81479
MIP 81479,81479
MIR184 81479,81479
MMP1 81479,81479
MSRA 81479,81479
MTMR7 81479,81479
MXRA8 81479,81479
MYH9 81479,81479
NDUFA1 81404,81479
NECTIN2 81479,81479
NECTIN3 81479,81479
NF2 81479,81479
NHS 81479,81479
NIPAL3 81479,81479
NRCAM 81479,81479
OCRL 81479,81479
OPA3 81479,81479
OTX2 81479,81479
P3H2 81479,81479
PAX6 81479,81479
PEAK1 81479,81479
PEX1 81479,81479
PEX10 81479,81479
PEX11B 81479,81479
PEX12 81479,81479
PEX13 81479,81479
PEX16 81479,81479
PEX2 81479,81479
PEX26 81479,81479
PEX3 81479,81479
PEX6 81479,81479
PEX7 81479,81479
PITX2 81479,81479
PITX3 81479,81479
PLD1 81479,81479
PLD3 81479,81479
POMT1 81406,81479
POMT2 81406,81479
PON2 81479,81479
PRKCI 81479,81479
PROX1 81479,81479
PRX 81405,81479
PTCH1 81479,81479
PTPRU 81479,81479
PXDN 81479,81479
RAB18 81479,81479
RAB3GAP1 81479,81479
RAB3GAP2 81479,81479
RECQL4 81479,81479
RHOBTB2 81479,81479
SC5D 81479,81479
SEC23A 81479,81479
SEMA3A 81479,81479
SIL1 81405,81479
SIPA1L3 81479,81479
SIX3 81479,81479
SIX5 81479,81479
SIX6 81479,81479
SLC16A12 81479,81479
SLC1A5 81479,81479
SLC25A13 81479,81479
SLC25A33 81479,81479
SLC25A40 81479,81479
SLC2A1 81405,81479
SLC33A1 81479,81479
SOX1 81479,81479
SOX2 81479,81479
SPINT2 81479,81479
SRD5A3 81479,81479
SREBF2 81479,81479
STEAP1 81479,81479
STEAP2 81479,81479
TACR1 81479,81479
TBC1D20 81479,81479
TDRD7 81479,81479
TMED3 81479,81479
TMEM114 81479,81479
TNPO1 81479,81479
TRAPPC6A 81479,81479
TTC14 81479,81479
UPF3B 81479,81479
VIM 81479,81479
VSX2 81479,81479
WFS1 81479,81479
YBX1 81479,81479
Test Code Test Copy Genes Panel CPT Code Gene CPT Codes Copy CPT Code Base Price
12001Genes x (171)81479 81404(x1), 81405(x6), 81406(x5), 81408(x2), 81479(x328) $1290 Order Options and Pricing

Pricing Comments

We are happy to accommodate requests for testing single genes in this panel or a subset of these genes. The price will remain the list price. If desired, free reflex testing to remaining genes on panel is available. Alternatively, a single gene or subset of genes can also be ordered via our Custom Panel tool.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).

Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).

Turnaround Time

3 weeks on average for standard orders or 2 weeks on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.

EMAIL CONTACTS

Genetic Counselors

Geneticist

  • Jamie Fox, PhD

Clinical Features and Genetics

Clinical Features

Cataracts are defined as opacification of the crystalline lens of the eye that result in abnormal refraction index and light scattering. Congenital cataracts (CC) are a serious and leading cause of reversible blindness in childhood. They account for one-tenth of the cases of childhood blindness (Francis and Moore. 2004. PubMed ID: 14743013). Estimated prevalence rate is 1.2 - 6.0 per 10,000 live births. Early diagnosis, surgery and optical correction have resulted in an improved outcome for infants with either unilateral or bilateral cataracts (Lambert and Drack. 1996. PubMed ID: 8724637).

Genetics

Only 10–25% of CC are hereditary. Cataracts are most often inherited as an autosomal dominant trait. CC also exhibit autosomal recessive or X-linked inheritance (Hejtmancik. 2008. PubMed ID: 18035564). X-linked cataract is seen in Nance-Horan syndrome (NHS), which is an especially rare disorder. NHS has cataract along with prominent dental findings, dysmorphic features, and intellectual disability (Toutain et al. 1997. PubMed ID: 9048931; Stambolian et al. 1990. PubMed ID: 1971992). Metabolic and some neurological disorders are also associated with CC (Cassidy and Taylor. 1999. PubMed ID: 10627826).

Currently, isolated or primary cataracts have been mapped to about 40 genetic loci, and over 25 of those are connected to pathogenic variants in specific genes. However, this number is constantly increasing. Among the candidate genes, about half of the identified pathogenic variants are in crystallins (CRYAA, CRYAB, CRYBA1, CRYBB1, CRYBB2, CRYBB3, CRYBA4, CRYGS, CRYGC, CRYGD), followed by about a quarter in lens-specific connexins (GJA3, GJA8). The remainder are divided among growth and transcription factors (HSF4, MAF, PITX3), membrane protein aquaporin-0 (AQP0, also known as MIP), cytoskeletal structural proteins (beaded filament structural proteins BFSP1 and BFSP2) and others (FYCO1, GCNT2, HSF4, LIM2, SIL1, TDRD7, FOXE3, CHMP4B, EPHA2, SLC33A1, AGK) (Hejtmancik. 2008. PubMed ID: 18035564).

The common genes associated with autosomal dominant inheritance include CRYAB, CRYBB2, CRYBA4, CRYGS, CRYGC, FOXE3, PITX3, CHMP4B, GJA3, MIP, EPHA2, BFSP2, SLC33A1, MAF, CRYBA1 (also known as CRYBA3), GJA8, CRYAA, HSF4, CRYGB, EYA1, MIR184, PAX6, SLC16A12, VIM and CRYGD. Common genes associated with autosomal recessive inheritance AGK, CRYBB3, FYCO1, GCNT2, LIM2, SIL1, TDRD7, BFSP1, PXDN,CTDP1, HYCC1/FAM126A, GALK1, P3H2 and CRYBB1. Pathogenic variants in NHS cause X-linked disorders. However, inheritance of the same variant in different families or within the same family can result in a varied clinical presentation of cataracts, which suggests the involvement of additional genes or modifying factors. On the other hand, identical clinical presentation of cataract is also possible due to variants in completely different genes (Hejtmancik. 2008. PubMed ID: 18035564; Santana and Waiswo. 2011. PubMed ID: 21779674; Chen et al. 2011. PubMed ID: 21636066; Pras et al. 2004. PubMed ID: 15161861; Haghighi et al. 2014. PubMed ID: 25208612).

Of note, we also offer focused test for cataracts that targets genes that are a relatively common cause of CC. See individual gene test descriptions for information on molecular biology of gene products and spectra of pathogenic variants.

Clinical Sensitivity - Sequencing with CNV PGxome

Whole exome sequencing identified pathogenic variants in 9 probands from 23 pedigrees affected by familial dominant cataracts (39%) in CRYAA, CRYBB1, CRYBB3, CRYGC, CRYGD, GJA8 and MIP (Reis et al. 2013. PubMed ID: 23508780). Screening in 25 Chinese families with congenital cataracts identified pathogenic variants in 10 families (40%) in 12 genes encoding crystallins (CRYAA, CRYAB, CRYBA1, CRYBB1, CRYBB2, CRYBB3, CRYBA4, CRYGS, CRYGC, CRYGD), and connexins (GJA3 and GJA8). Approximately 32% of the families had pathogenic variants in crystallin genes and 8% of the families had pathogenic variants in connexin genes (Sun et al. 2011. PubMed ID: 21866213). In another study it was reported that the pathogenic variant detection rate is about 73% in the familial cases (16/22), and 68% in the sporadic cases (17/25). In the same study, ~61% of the pathogenic variants were in crystallin and gap junction genes (Ma et al. 2016. PubMed ID: 26694549).

To our knowledge, no studies have indicated what percentage of the cataract population has copy number variants or which genes have a high frequency of deletion/duplication.

Testing Strategy

This test is performed using Next-Gen sequencing with additional Sanger sequencing as necessary.

This panel typically provides 99.5% coverage of all coding exons of the genes plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define coverage as ≥20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).

Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).

Indications for Test

Patients with multiple types of nonsyndromic and syndromic cataracts.

Genes

Official Gene Symbol OMIM ID
ABCB6 605452
ADAMTS10 608990
AGK 610345
AGPS 603051
AKAP14 300462
ALDH18A1 138250
ALPL 171760
B3GLCT 610308
BCOR 300485
BEST1 607854
BFSP1 603307
BFSP2 603212
BMP4 112262
BMP7 112267
CAPN15 603267
CCNP 0
CHMP4B 610897
COL11A1 120280
COL18A1 120328
COL2A1 120140
COL4A1 120130
COL4A2 120090
CRYAA 123580
CRYAB 123590
CRYBA1 123610
CRYBA4 123631
CRYBB1 600929
CRYBB2 123620
CRYBB3 123630
CRYGB 123670
CRYGC 123680
CRYGD 123690
CRYGS 123730
CTDP1 604927
CYP27A1 606530
DHCR7 602858
ELP4 606985
EPG5 615068
EPHA2 176946
ERCC1 126380
ERCC2 126340
ERCC5 133530
ERCC6 609413
ERCC8 609412
ESCO2 609353
EVA1A 618990
EYA1 601653
FAM131A 0
FBN1 134797
FOXC1 601090
FOXE3 601094
FTL 134790
FYCO1 607182
FZD4 604579
GALK1 604313
GCNT2 600429
GJA1 121014
GJA3 121015
GJA8 600897
GJC3 611925
GLA 300644
GNPAT 602744
GPR160 0
GRWD1 610597
HCCS 300056
HMX1 142992
HSF4 602438
HYCC1 610531
INPP5B 147264
JAM3 606871
KLHL21 616262
LAMB1 150240
LARGE1 603590
LCT 603202
LENG8 616575
LIM2 154045
LMX1B 602575
LRP5 603506
LTBP2 602091
LTBP3 602090
MAB21L1 601280
MAF 177075
MAN1C1 616772
MAN2B1 609458
MAP6D1 610593
MECR 608205
MEIS1 601739
MIP 154050
MIR184 613146
MMP1 120353
MSRA 601250
MTMR7 603562
MXRA8 617293
MYH9 160775
NDUFA1 300078
NECTIN2 600798
NECTIN3 607147
NF2 607379
NHS 300457
NIPAL3 0
NRCAM 601581
OCRL 300535
OPA3 606580
OTX2 600037
P3H2 610341
PAX6 607108
PEAK1 614248
PEX1 602136
PEX10 602859
PEX11B 603867
PEX12 601758
PEX13 601789
PEX16 603360
PEX2 170993
PEX26 608666
PEX3 603164
PEX6 601498
PEX7 601757
PITX2 601542
PITX3 602669
PLD1 602382
PLD3 615698
POMT1 607423
POMT2 607439
PON2 602447
PRKCI 600539
PROX1 601546
PRX 605725
PTCH1 601309
PTPRU 602454
PXDN 605158
RAB18 602207
RAB3GAP1 602536
RAB3GAP2 609275
RECQL4 603780
RHOBTB2 607352
SC5D 602286
SEC23A 610511
SEMA3A 603961
SIL1 608005
SIPA1L3 616655
SIX3 603714
SIX5 600963
SIX6 606326
SLC16A12 611910
SLC1A5 109190
SLC25A13 603859
SLC25A33 610816
SLC25A40 610821
SLC2A1 138140
SLC33A1 603690
SOX1 602148
SOX2 184429
SPINT2 605124
SRD5A3 611715
SREBF2 600481
STEAP1 604415
STEAP2 605094
TACR1 162323
TBC1D20 611663
TDRD7 611258
TMED3 0
TMEM114 611579
TNPO1 602901
TRAPPC6A 610396
TTC14 0
UPF3B 300298
VIM 193060
VSX2 142993
WFS1 606201
YBX1 154030
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT

Diseases

Name Inheritance OMIM ID
Age-Related Macular Degeneration 5 AR 613761
Aniridia 2 AD 617141
Anterior Segment Mesenchymal Dysgenesis AD 107250
Aphakia, Congenital Primary AR 610256
Atrioventricular Septal Defect AD 600309
Axenfeld-Rieger Syndrome Type 3 AD 602482
Axenfeld-Rieger syndrome, type 1 AD 180500
Ayme-Gripp Syndrome AD 601088
Baller-Gerold Syndrome AR 218600
Bestrophinopathy, Autosomal Recessive 611809
Blood Group--I System AD 110800
Brain Small Vessel Disease With Hemorrhage AD 607595
Cataract 10 AD 600881
Cataract 11 AD 610623
Cataract 12 AD 611597
Cataract 13 AR 116700
Cataract 14 AD 601885
Cataract 15 AD 615274
Cataract 16 AD 613763
Cataract 17 AD 611544
Cataract 18 AR 610019
Cataract 19 AR 615277
Cataract 2 AD 604307
Cataract 20 AD 116100
Cataract 21 AD 610202
Cataract 22 AD 609741
Cataract 23 610425
Cataract 3 AD 601547
Cataract 30 AD 116300
Cataract 31 AD 605387
Cataract 33 AD 611391
Cataract 34, multiple types AD 612968
Cataract 36 AR 613887
Cataract 38 AR 614691
Cataract 39 AD 615188
Cataract 4 AD 115700
Cataract 41 AD 116400
Cataract 45 AR 616851
Cataract 47 AD 612018
Cataract 5 AD 116800
Cataract 6 AD 116600
Cataract 9 AD 604219
Cataract, Congenital, X-Linked AD 302200
Cataract, Zonular Pulverulent 1 AD 116200
Cerebellar, ocular, craniofacial, and genital syndrome AR 618479
Cerebro-Oculo-Facio-Skeletal Syndrome AR 214150
Cerebrooculofacioskeletal Syndrome 2 AR 610756
Cerebrooculofacioskeletal syndrome 3 AR 616570
Cerebrooculofacioskeletal Syndrome 4 AR 610758
Cerebrotendinous Xanthomatosis AR 213700
Charcot-Marie-Tooth Disease, Type 3 AD 145900
Charcot-Marie-Tooth Disease, Type 4F AR 614895
Citrin Deficiency AR 605814
Citrullinemia Type II AR 603471
Cockayne Syndrome Type I AR 216400
Coloboma, Ocular AD 120200
Congenital Aniridia AD 106210
Congenital Cataracts, Facial Dysmorphism, And Neuropathy AR 604168
Congenital Cataracts, Hearing Loss, and Neurodegeneration AR 614482
Congenital Disorder Of Glycosylation Type 1Q AR 612379
Congenital Secretory Diarrhea, Sodium Type AR 270420
Corneal Opacification and Other Ocular Anomalies AR 269400
Deficiency Of Galactokinase AR 230200
Dent Disease 2 XL 300555
Diabetes Mellitus And Insipidus With Optic Atrophy And Deafness AR 222300
Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities AR 617282
Ectopia Lentis, Isolated, Autosomal Dominant AD 129600
EDICT Syndrome AD 614303
Exudative Vitreoretinopathy 4 AD 601813
Familial Exudative Vitreoretinopathy AD 133780
Foveal Hypoplasia And Presenile Cataract Syndrome AD 136520
Glaucoma 3, Primary Congenital, D 613086
Heimler syndrome 1 AR 234580
Heimler syndrome 2 AR 616617
Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Cataracts AR 613730
Hyperferritinemia Cataract Syndrome AD 600886
Iridogoniodysgenesis Type1 AD 601631
Iridogoniodysgenesis, Dominant Type AD 137600
Kahrizi syndrome AR 612713
Keratitis, Hereditary AD 148190
Knobloch Syndrome 1 AR 267750
Lowe Syndrome XL 309000
Marfan lipodystrophy syndrome AD 616914
Marfan Syndrome AD 154700
Marinesco-Sjogren Syndrome AR 248800
Marshall Syndrome AD 154780
Martsolf Syndrome AR 212720
Mass Syndrome AD 604308
Microphthalmia Syndromic 3 AD 206900
Microphthalmia Syndromic 5 AD 610125
Microphthalmia Syndromic 6 AD 607932
Microphthalmia, Isolated 2 610093
Microphthalmia, Isolated, With Coloboma 3 610092
Microphthalmia, isolated, with coloboma 7 AD 614497
Microspherophakia and/or Megalocornea, with Ectopia Lentis and with or without Secondary Glaucoma AR 251750
Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 2 AR 613150
Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 6 AR 613154
Myopia, High, with Cataract And Vitreoretinal Degeneration AR 614292
Nail-Patella Syndrome AD 161200
Nance-Horan Syndrome XL 302350
Oculoauricular Syndrome AR 612109
Oculodentodigital Dysplasia AD 164200
Oculodentodigital Dysplasia, Autosomal Recessive AR 257850
Oculofaciocardiodental Syndrome XL 300166
Optic Atrophy And Cataract, Autosomal Dominant AD 165300
Optic Disc Anomalies with Retinal and/or Macular Dystrophy AR 212550
Optic Nerve Hypoplasia, Bilateral AD 165550
Peroxisome biogenesis disorder 10A (Zellweger) AR 614882
Peroxisome biogenesis disorder 10B AR 617370
Peroxisome biogenesis disorder 11A (Zellweger) AR 614883
Peroxisome biogenesis disorder 11B AR 614885
Peroxisome Biogenesis Disorder 14B AR 614920
Peroxisome biogenesis disorder 1A (Zellweger) AR 214100
Peroxisome biogenesis disorder 1B (NALD/IRD) AR 601539
Peroxisome biogenesis disorder 3A (Zellweger) AR 614859
Peroxisome biogenesis disorder 3B AR 266510
Peroxisome biogenesis disorder 4A (Zellweger) AR 614862
Peroxisome biogenesis disorder 4B AD 614863
Peroxisome biogenesis disorder 5A (Zellweger) AR 614866
Peroxisome biogenesis disorder 5B AR 614867
Peroxisome biogenesis disorder 6A (Zellweger) AR 614870
Peroxisome biogenesis disorder 6B AR 614871
Peroxisome biogenesis disorder 7A (Zellweger) AR 614872
Peroxisome biogenesis disorder 7B AR 614873
Peroxisome biogenesis disorder 8A, (Zellweger) AR 614876
Peroxisome biogenesis disorder 8B AR 614877
Peroxisome Biogenesis Disorder 9B 614879
Peters Anomaly AD 604229
Peters Plus Syndrome AR 261540
Rapadilino Syndrome AR 266280
Retinal arteries, tortuosity of AD 180000
Retinitis Pigmentosa 50 AD 613194
Rhizomelic Chondrodysplasia Punctata Type 1 AR 215100
Rhizomelic Chondrodysplasia Punctata Type 2 AR 222765
Rhizomelic Chondrodysplasia Punctata, Type 3 AR 600121
Ring Dermoid Of Cornea AD 180550
Roberts Syndrome AR 268300
Rothmund-Thomson Syndrome AR 268400
Sengers syndrome AR 212350
Smith-Lemli-Opitz Syndrome AR 270400
Spastic Paraplegia 42 AD 612539
Stickler Syndrome Type 1 AD 108300
Stickler Syndrome, Type 2 AD 604841
Stickler Syndrome, Type I, Nonsyndromic Ocular AD 609508
Vici Syndrome AR 242840
Vitelliform Dystrophy AD 153700
Vitreoretinochoroidopathy Dominant AD 193220
Walker-Warburg Congenital Muscular Dystrophy AR 236670
Warburg Micro Syndrome 1 AR 600118
Warburg Micro Syndrome 2 AR 614225
Warburg Micro Syndrome 3 AR 614222
Warburg Micro Syndrome 4 AR 615663
Weill-Marchesani Syndrome 1 AR 277600
Weill-Marchesani Syndrome 2 AD 608328
Weill-Marchesani Syndrome 3 AR 614819
Wolfram-Like Syndrome, Autosomal Dominant AD 614296

Related Test

Name
PGxome®

Citations

  • Cassidy and Taylor. 1999. PubMed ID: 10627826
  • Chen et al. 2011. PubMed ID: 21636066
  • Francis and Moore. 2004. PubMed ID: 14743013
  • Haghighi et al. 2014. PubMed ID: 25208612
  • Hejtmancik. 2008. PubMed ID: 18035564
  • Lambert and Drack. 1996. PubMed ID: 8724637
  • Ma et al. 2016. PubMed ID: 26694549
  • Pras et al. 2004. PubMed ID: 15161861
  • Reis et al. 2013. PubMed ID: 23508780
  • Santana and Waiswo. 2011. PubMed ID: 21779674
  • Stambolian et al. 1990. PubMed ID: 1971992
  • Sun et al. 2011. PubMed ID: 21866213
  • Toutain et al. 1997. PubMed ID: 9048931

Ordering/Specimens

Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page

If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.


Specimen Types

Specimen Requirements and Shipping Details

PGxome (Exome) Sequencing Panel

PGnome (Genome) Sequencing Panel

loading Loading... ×

ORDER OPTIONS

An error has occurred while calculating the price. Please try again or contact us for assistance.

View Ordering Instructions

1) Select Test Method (Platform)


1) Select Test Type


2) Select Additional Test Options

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: loading
Patient Prompt Pay Price: loading
A patient prompt pay discount is available if payment is made by the patient and received prior to the time of reporting.
Show Patient Prompt Pay Price
×
Copy Text to Clipboard
×